At a glance
ClinicalIndex Comparison RecordN/ACompleted· 216 enrolled
Drug / intervention
CRT-Ddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CAPTure Information Via Automatic Threshold Evaluation
In Brief
A clinical study evaluating CRT-D for Heart Failure. Completed, enrolled 216 participants across 36 sites.
Detailed Summary
This study will evaluate the PaceSafe Right Ventricular Autothreshold (RVAT) and Left Ventricular Autothreshold (LVAT) features for AUTOGEN Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartApr 2014
Primary CompletionJan 2016
Study CompletionMay 2017
TodayJul 2026
First PostedMar 27, 2014
Enrollment StartApr 1, 2014
Primary CompletionJan 1, 2016
Study CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.3 years ago
Interventions
CRT-Ddevice
For all subjects with the AUTOGEN CRT-D, the autothreshold algorithms will be evaluated